Nashville General Hospital at Meharry — Nashville, Tennessee

Nashville General Hospital at Meharry is a clinical research site located in Nashville, Tennessee, United States 37208.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Nashville General Hospital at Meharry has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Bladder Cancer, Cervical Cancer, Esophageal Cancer.

Sponsors: Fox Chase Cancer Center, Genentech, Inc., Alliance Foundation Trials, LLC..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville General Hospital at Meharry?

Nashville General Hospital at Meharry has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville General Hospital at Meharry conducted?

Nashville General Hospital at Meharry has 3 clinical trials on record, with 2 currently active. Their work covers Bladder Cancer, Cervical Cancer, Esophageal Cancer.

Is Nashville General Hospital at Meharry accredited by Crixeo Health?

Nashville General Hospital at Meharry has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville General Hospital at Meharry?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.